Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides pharmaceutical research and clinical research services in China. The company offers service platform f...
AHWB released its performance for the first three quarters, with a net profit attributable to the parent company of 33.1106 million yuan, a decrease of 57.44%
The innovative drug concept fell at the beginning of the session, with Cosunter down 10%
The medical services sector has seen a short-term decline, with Kingchem falling over 8%
Ergothioneine receives attention, multiple listed companies respond to related questions
AHWB released its 2024 annual performance, with a net profit attributable to the parent company of 85.5307 million yuan, a decrease of 20.87%
AHWB released its first-quarter performance, with a net profit attributable to the parent company of 11.8493 million yuan, a decrease of 60.09%